27-hydroxycholesterol has been researched along with gw 3965 in 2 studies
Studies (27-hydroxycholesterol) | Trials (27-hydroxycholesterol) | Recent Studies (post-2010) (27-hydroxycholesterol) | Studies (gw 3965) | Trials (gw 3965) | Recent Studies (post-2010) (gw 3965) |
---|---|---|---|---|---|
345 | 11 | 214 | 235 | 0 | 164 |
Protein | Taxonomy | 27-hydroxycholesterol (IC50) | gw 3965 (IC50) |
---|---|---|---|
Alpha-glucosidase MAL32 | Saccharomyces cerevisiae S288C | 4.8 | |
Oxysterols receptor LXR-beta | Homo sapiens (human) | 0.47 | |
Oxysterols receptor LXR-alpha | Homo sapiens (human) | 0.5691 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bussolino, F; Morello, F; Mulatero, P; Noghero, A; Saglio, E; Schiavone, D; Veglio, F; Verhovez, A; Williams, TA | 1 |
Collins, F; Cousins, FL; Esnal Zufiaurre, A; Gibson, DA; Saunders, PTK | 1 |
2 other study(ies) available for 27-hydroxycholesterol and gw 3965
Article | Year |
---|---|
LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
Topics: Anticholesteremic Agents; Benzoates; Benzylamines; Cells, Cultured; Chemokines; Cholesterol; E-Selectin; Endothelial Cells; Gene Expression Profiling; Gene Expression Regulation; Humans; Hydrocarbons, Fluorinated; Hydroxycholesterols; Inflammation Mediators; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Liver X Receptors; Orphan Nuclear Receptors; RNA Interference; RNA, Messenger; Signal Transduction; Sulfonamides; Transcription Factors; Transfection; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2009 |
The impact of 27-hydroxycholesterol on endometrial cancer proliferation.
Topics: Adenocarcinoma; Benzoates; Benzylamines; Cell Proliferation; Endometrial Neoplasms; Endometrium; Female; Humans; Hydroxycholesterols; Hysterectomy | 2018 |